Pharmaceutical Business review

SIMM selects Instem Provantis preclinical software solution suite

Instem claimed that Provantis is a preclinical research technology solution that is easy to use and will offer dual language operation and protocol-driven automation that will produce quality study output in greatly reduced timescales.

Instem CEO Phil Reason said that as the primary participant in the newly established Research Center for Modernisation of Traditional Chinese Medicine, they were honored that SIMM has chosen Instem’s Provantis software to automate their research laboratories.

SIMM is expected to be using Instem’s SaaS (Software-as-a-Service) model offering simpler, cost effective ways to provide software functionality, maintenance, and support over the Internet.